SCHEMBL1667289

SCHEMBL1667289

CC(OC(=O)C1CCCC(C)C1C(=O)OC(C)c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
RECQL P46063 1/20 0.40
TAAR1 Q96RJ0 1/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KDM4E B2RXH2 1/20 0.36
GRIN2B Q13224 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 2/20 0.36
TSHR P16473 2/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 2/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667292 0.93 HCAR2 (0.40) HCAR2KMT2AMEN1RECQLTAAR1
SCHEMBL1664178 0.86 CHRM2 (0.40) KMT2AMEN1KDM4ETSHRMAPK1
SCHEMBL1665342 0.84 HCAR2 (0.49) HCAR2RECQLTAAR1KCNQ3KCNQ2
SCHEMBL9179049 0.82 HCAR2 (0.44) HCAR2KMT2AMEN1RECQLKDM4E
SCHEMBL1665255 0.81 PRSS1 (0.38) KMT2AMEN1KDM4ETSHRCYP3A4
SCHEMBL1665343 0.80 TAAR1 (0.53) HCAR2KMT2AMEN1RECQLTAAR1
SCHEMBL1196855 0.78 EPHX1 (0.37)
SCHEMBL7873412 0.77 HCAR2 (0.40) HCAR2KMT2AMEN1RECQLKDM4E
SCHEMBL7872084 0.77 HCAR2 (0.40) HCAR2KMT2AMEN1RECQLKDM4E
SCHEMBL7864740 0.77 HCAR2 (0.40) HCAR2KMT2AMEN1RECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC HCAR2 1123/4885KMT2A 1323/4885MEN1 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.